Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase

Vascular Pharmacology

Volumn 59, Issue 3-4, 2013, Pages 103-111

  Dalaklioglu, Selvinaz ^a   Tasatargil, Arda ^a   Kale, Sule ^a   Tanriover, Gamze ^a   Dilmac, Sayra ^a   Erin, Nuray ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Breast carcinoma; Endothelial dysfunction; NADPH oxidase; TNF

Indexed keywords

ACETYLCHOLINE; APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOPROTEIN GP 91; INFLIXIMAB; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHLORIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; BREAST CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THORACIC AORTA; TUMOR VOLUME; VASCULAR ENDOTHELIUM;

BREAST CARCINOMA; ENDOTHELIAL DYSFUNCTION; NADPH OXIDASE; TNF-Α;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NADPH OXIDASE; NEOPLASM METASTASIS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 84885290741     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.07.008     Document Type: Article

References (66)

1. Adachi T., Toishi T., Takashima E., Hara H. Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol Pharm Bull 2006, 29:2095-2098.
2. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 2006, 72:1605-1621.
3. Anbuselvama C., Vijayavelb K., Balasubramanian M.P. Protective effect of Operculina turpethum against 7,12-dimethyl benz(a)anthracene induced oxidative stress with reference to breast cancer in experimental rats. Chem Biol Interact 2007, 168:229-236.
4. Anderson H.D., Rahmutula D., Gardner D.G. Tumor necrosis factor-alpha inhibits endothelial nitric oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 2004, 279:963-969.
5. Ardizzoia A., Lissoni P., Brivio F., Tisi E., Perego M.S., Grassi M.G., et al. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents 1992, 6:103-107.
6. Aslakson C.J., Miller F.R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992, 52:1399-1405.
7. Boyle P., Howell A. The globalization of breast cancer. Breast Cancer Res 2010, 12(Suppl. 4):S7.
8. Carneiro F.S., Webb R.C., Tostes R.C. Emerging role for TNF-α in erectile dysfunction. J Sex Med 2010, 7:3823-3834.
9. Chandel N.S., Trzyna W.C., McClintock D.S., Schumacker P.T. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 2000, 165:1013-1021.
10. Chia S., Qadan M., Newton R., Ludlam C.A., Fox K.A., Newby D.E. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol 2003, 23:695-701.
11. Drummond G.R., Selemidis S., Griendling K.K., Sobey C.G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011, 10:453-471.
12. Erin N., Akdas Barkan G., Harms J.F., Clawson G.A. Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul Pept 2008, 151:35-42.
13. Erin N., Kale S., Tanriöver G., Köksoy S., Duymuş O., Korcum A.F. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma. Breast Cancer Res Treat 2013, 139(3):677-689.
14. Erin N., Tanriover G., Kale S., Duymus O. Differential effects of liver metastatic and brain metastatic subset of murine breast carcinoma cells. Cancer Res 2011, 71(Suppl. 8):2426.
15. Erin N., Wang N., Xin P., Bui V., Weisz J., Barkan G.A., et al. Altered gene expression in breast cancer liver metastases. Int J Cancer 2009, 124:1503-1516.
16. Fisher S.M., Floyd R.A., Copeland E.S. Workshop report from the division of research grants, national institute of health. Oxy radicals in carcinogenesis - a chemical pathology study section workshop. Cancer Res 1983, 43:5631-5637.
17. Fleming I., Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1-R12.
18. Fresquet F., Pourageaud F., Leblais V., Brandes R.P., Savineau J.P., Marthan R., et al. Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 2006, 148:714-723.
19. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
20. Fulton D., Gratton J.P., Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J Pharmacol Exp Ther 2001, 299:818-824.
21. Gao X., Belmadani S., Picchi A., Xu X., Potter B.J., Tewari-Singh N., et al. Tumor necrosis factor-α induces endothelial dysfunction in Leprdb mice. Circulation 2007, 115:245-254.
22. Gong Y., Sun X., Huo L. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology 2005, 46:24-30.
23. Haklar G., Sayin-Ozveri E., Yuksel M., Aktan A.O., Yalcin A.S. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 2001, 165:219-224.
24. Hamed E.A., Zakhary M.M., Maximous D.W. Apoptosis, angiogenesis, inflammation and oxidative stress: basic interactions in patients with early and metastatic breast cancer. J Cancer Res Clin Oncol 2012, 138:999-1009.
25. Hürlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002, 106:2184-2187.
26. Zhang H., Zhang J., Ungvari Z., Zhang C. Resveratrol improves endothelial function: role of TNFα and vascular oxidative stress. Arterioscler Thromb Vasc Biol 2009, 29:1164-1171.
27. Herrera A.C., Panis C., Victorino V.J., Campos F.C., Colado-Simão A.N., Cecchini A.L., et al. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunol Immunother 2012, 61:2193-2201.
28. Heumuller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schroder K., et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51:211-217.
29. Himmetoglu S., Dincer Y., Ersoy Y.E., Bayraktar B., Celik V., Akcay T. DNA oxidation and antioxidant status in breast cancer. J Investig Med 2009, 57:720-723.
30. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
31. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
32. Kasapović J., Pejić S., Todorović A., Stojiljković V., Pajović S.B. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 2008, 26:723-730.
33. Kennovin G.D., Flitney F.W., Hirst D.G. "Upstream" modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour. Adv Exp Med Biol 1994, 345:411-416.
34. Kitakata H., Nemoto-Sasaki Y., Takahashi Y., Kondo T., Mai M., Mukaida N. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 2002, 62:6682-6687.
35. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
36. Madge L.A., Pober J.S. TNF signaling in vascular endothelial cells. Exp Mol Pathol 2001, 70:317-325.
37. Makino N., Maeda T., Sugano M., Satoh S., Watanabe R., Abe N. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells. J Diabetes Complications 2005, 19:347-355.
38. Miller A.A., Drummond G.R., Schmidt H.H., Sobey C.G. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res 2005, 97:1055-1062.
39. Mudau M., Genis A., Lochner A., Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr 2012, 23:222-231.
40. Oberley L.W., Oberley T.D. Free radicals, cancer, and aging. Free radicals, aging and degenerative diseases 1986, 325-371. Alan R Liss, New York. J.E. Johnson, R. Walford, D. Harman, J. Miquel (Eds.).
41. Ogawa A., Kanda T., Sugihara S., Masumo H., Kobayashi I. Risk factors for myocardial infarction in cancer patients. J Med 1995, 26:221-233.
42. Pande D., Negi R., Karki K., Khanna S., Khanna R.S., Khanna H.D. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma. Transl Res 2012, 160:411-418.
43. Panis C., Victorino V.J., Herrera A.C.S.A., Freitas L.F., De Rossi T., Campos F.C., et al. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat 2012, 133:881-888.
44. Patnaik J.L., Byers T., DiGuiseppi C., Dabelea D., Denberg T.D. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 2011, 13:R64.
45. Patnaik J.L., Byers T., Diguiseppi C., Denberg T.D., Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011, 103:1101-1111.
46. Picchi A., Gao X., Belmadani S., Potter B.J., Focardi M., Chilian W.M., et al. Tumor necrosis factor-α induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006, 99:69-77.
47. Poredos P. Endothelial dysfunction and cardiovascular disease. Pathophysiol Haemost Thromb 2002, 32:274-277.
48. Ray G., Batra S., Shukla N.K., Deo S., Raina V., Ashok S., et al. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 2000, 59:163-170.
49. Ródenas J., Mitjavila M.T., Carbonell T. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes. Am J Physiol 1998, 274:C827-C830.
50. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994, 120:104-110.
51. Schonberg M.A., Marcantonio E.R., Ngo L., Li D., Silliman R.A., McCarthy E.P. Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol 2011, 29:1570-1577.
52. Sheen-Chen S.M., Chen W.J., Eng H.L., Chou F.F. Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 1997, 43:211-215.
53. Sidiropoulos P.I., Siakka P., Pagonidis K., Raptopoulou A., Kritikos H., Tsetis D., et al. Sustained improvement of vascular endothelial function during anti-TNFα treatment in rheumatoid arthritis patients. Scand J Rheumatol 2009, 38:6-10.
54. Singla A., Kumar G., Bardia A. Personalizing cardiovascular disease prevention among breast cancer survivors. Curr Opin Cardiol 2012, 27:515-524.
55. Syngle A., Vohra K., Sharma A., Kaur L. Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade. Clin Rheumatol 2010, 29:763-770.
56. Szlosarek P., Charles K.A., Balkwill F.R. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer 2006, 42:745-750.
57. Takac I., Schröder K., Brandes R.P. The Nox family of NADPH oxidases: friend or foe of the vascular system?. Curr Hypertens Rep 2012, 14:70-78.
58. Tousoulis D., Briasoulis A., Papageorgiou N., Tsioufis C., Tsiamis E., Toutouzas K., et al. Oxidative stress and endothelial function: therapeutic interventions. Recent Pat Cardiovasc Drug Discov 2011, 6:103-114.
59. Vendramini-Costa D.B., Carvalho J.E. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 2012, 18:3831-3852.
60. Virdis A., Santini F., Colucci R., Duranti E., Salvetti G., Rugani I., et al. Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011, 58:238-247.
61. Wang H., Li H., Hou Z., Pan L., Shen X., Li G. Role of oxidative stress in elevated blood pressure induced by high free fatty acids. Hypertens Res 2009, 32:152-158.
62. Warnholtz A., Mollnau H., Oelze M., Wendt M., Münzel T. Antioxidants and endothelial dysfunction in hyperlipidemia. Curr Hypertens Rep 2001, 3:53-60.
63. Zhang D.X., Yi F.X., Zou A.P., Li P.L. Role of ceramide in TNF-α-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am J Physiol Heart Circ Physiol 2002, 283:H1785-H1794.
64. Zhang C., Wu J., Xu X., Potter B.J., Gao X. Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury. Basic Res Cardiol 2010, 105:453-464.
65. Zhang H., Park Y., Wu J., Chen X.P., Lee S., Yang J., et al. Role of TNF-α in vascular dysfunction. Clin Sci 2009, 116:219-230.
66. Zhang R., Ran H.H., Ma J., Bai Y.G., Lin L.J. NAD(P)H oxidase inhibiting with apocynin improved vascular reactivity in tail-suspended hindlimb unweighting rat. J Physiol Biochem 2012, 68:99-105.